Keum Kang Steel Co., Ltd. (KOSDAQ:053260)
South Korea
· Delayed Price · Currency is KRW 7,610.00
+1,750.00 (29.86%)
At close: Apr 28, 2026
Keum Kang Steel Revenue
In the year 2025, Keum Kang Steel had annual revenue of 177.22B KRW, down -11.87%. Keum Kang Steel had revenue of 42.40B in the quarter ending December 31, 2025, a decrease of -27.08%.
Revenue
177.22B
Revenue Growth
-11.87%
P/S Ratio
0.67
Revenue / Employee
2.33B
Employees
76
Market Cap
119.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 177.22B | -23.86B | -11.87% |
| Dec 31, 2024 | 201.08B | -24.28B | -10.77% |
| Dec 31, 2023 | 225.36B | -18.86B | -7.72% |
| Dec 31, 2022 | 244.22B | 8.00B | 3.39% |
| Dec 31, 2021 | 236.22B | 61.04B | 34.84% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samik Pharmaceutical Company LTD. | 60.02B |
| Sinsin Pharmaceutical | 113.78B |
| Polaris AI Pharma | 63.94B |
| Quratis | 2.46B |
| Cellid, | 4.17B |
| CTCBIO | 123.77B |
| JNK Global | 147.29B |
| Choong Ang Vaccine Laboratory | 39.19B |